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The study is to investigate a Hybrid IMRT/VMAT technique which combines intensity modulated radiation therapy (IMRT) and
volumetricmodulated arc therapy (VMAT) for the treatment of nonsmall cell lung cancer (NSCLC). Two partial arcs VMAT, 5-field
IMRT, and hybrid plans were created for 15 patients with NSCLC. The hybrid plans were combination of 2 partial arcs VMAT and
5-field IMRT.The dose distribution of planning target volume (PTV) and organs at risk (OARs) for hybrid technique was compared
with IMRT and VMAT.The monitor units (MUs) and treatment delivery time were also evaluated. Hybrid technique significantly
improved the target conformity and homogeneity compared with IMRT and VMAT.Themean delivery time of IMRT, VMAT, and
hybrid plans was 280 s, 114 s, and 327 s, respectively. The mean MUs needed for IMRT, VMAT, and hybrid plans were 933, 512, and






, and MLD of normal lung compared with VMAT and spared the OARs




, and mean lung dose (MLD) of normal lung compared with IMRT.
Hybrid IMRT/VMAT can be a viable radiotherapy technique with better plan quality.
1. Introduction
Treatment of nonsmall cell lung cancer (NSCLC) remains one
of the major challenges for radiotherapy. Three-dimensional
conformal radiotherapy (3D-CRT) has proved to be a promis-
ing treatmentmethod for NSCLC allowing higher doses to be
delivered to the target by improved shaping of radiation por-
tals and conformal avoidance of normal structures compared
with the conventional radiotherapy [1]. Compared to 3D-
CRT, intensity modulated radiation therapy (IMRT) further
significantly improved the dose conformity and sparing of
organs at risk [2]. However, the longer treatment time in
IMRT could increase the discomfort of the patients during
the treatment, and more MUs could increase the incidence
of secondary radiation-induced cancer [3, 4]. Volumetric
modulated arc therapy (VMAT) provided more conformal
target coverage and better sparing of organs at risk (OARs),
with shorter treatment delivery time and fewer MUs than
IMRT in treating cancers of different sites [5–9]. However,










[12, 14, 15] have been showed
to be the predictors of the radiation pneumonitis.
The aim of this study is to investigate a radiotherapy
technique we call Hybrid IMRT/VMAT for nonsmall cell
lung cancer treatments. The dosimetric quality and delivery
efficiency of the Hybrid IMRT/VMAT technique were eval-
uated by comparing with IMRT and VMAT for 15 nonsmall
cell lung cancer patients.
2. Methods and Materials
2.1. Patients’ Characteristics. Fifteen NSCLC patients who
underwent radiotherapy from January 2012 to April 2013 in
our hospital were retrospectively selected for this study.
2.2. Delineation of Target Volumes and Critical Structures.
The patients underwent four-dimensional computed tomog-
raphy (4D-CT) (Brilliance Big Bore, PhilipsMedical Systems,
Cleveland, USA) scanning in 5mm slice thickness, 0.5 sec-
onds of scan time per rotation during normal breathing in
supine arm-up position.The gross tumor volume (GTV) was
defined as the visualization of any gross tumor and lymph
nodes involved (>1 cm on CT). An internal target volume
(ITV) was obtained as a union of the GTVs from all respi-
ratory motion phases. The CTV was defined as the potential
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Table 1: Treatment planning objectives used for Hybrid IMRT/
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PTV is planning target volume.
∗
𝑉𝑁 is percentage volume of OARs receiving at least𝑁Gy of radiation dose.
harboring microscopic disease. The PTV was created by
expanding the CTVby 0.5 cm.TheOARs delineated included
the double lungs, normal lung, spinal cord, esophagus, and
heart. We defined the double lungs minus GTV as normal
lung. The spinal cord and the esophagus were contoured
starting at least 2 cm above the superior extent of the PTV
and continuing on every CT slice to at least 2 cm below the
inferior extent of the PTV. No margins were added to the
organs at risk.
2.3. Treatment Planning. Hybrid IMRT/VMAT, IMRT, and
VMAT plans were designed for each patient. The prescribed
dose to the PTV was 66Gy in 33 fractions. The plans were
normalized to cover 95% of the PTV with 100% of the
prescribed dose. The optimization objectives and constraints
shown in Table 1 were the same for the three techniques.
Eclipse 10.0 (Varian, Palo Alto, CA) treatment planning
system was used for all treatment planning, utilizing 6MV
photon beams generated from Varian Trilogy linac equipped
with a 120 leaf MillenniumMultileaf Collimator (MLC).
2.4. IMRT. The beam angles of IMRT were initially opti-
mized by the beam angle optimization algorithm (Varian
Eclipse 10.0); a set of initial optimization objectives were
loaded into the treatment planning system. The number
of the fields was confined to five. Some beam angles were
adjusted according to the experience of the dosimetrists, if
the results of the beam angle optimization did not satisfy the
dosimetric criteria. The plans were iteratively optimized to
obtain the optimal PTV coverage and OARs sparing. After
inverse planning, the leaf sequences using sliding window
technique were generated for IMRT plans.
2.5. VMAT. All VMAT plans were generated using 2 partial
arcs. The collimator angle varied between 0∘ and 90∘ accord-
ing to the shape of the target while minimizing the leakage,
tongue, and groove effects. Other planning parameters were
MLCmotion speed 0 to 2.5 cm/s, gantry rotation speed 0.5 to
4.8 degrees/s, and dose rate 0 to 600MU/min.
2.6. Hybrid IMRT/VMAT. The Hybrid IMRT/VMAT tech-
nique integrates IMRT andVMAT.The IMRTpart consists of
a 5-field IMRT plan (Hybrid-IMRT), which contributes half
of the total prescribed dose, while the VMAT parts consist
of a 2 partial arcs VMAT plan (Hybrid-VMAT) which was
optimized with the IMRT plan as a base plan, to deliver the
other half of the prescribed dose.
2.7. Dosimetric Evaluation. The dosimetric quality of the
Hybrid IMRT/VMAT plans was evaluated by comparison
with IMRT and VMAT. To evaluate the dose distribution
of the target, we calculated the minimal dose delivered to
the 98% of the target volume (𝐷
98%), the maximum dose
delivered to the 2% of the target volume (𝐷
2%), the median
absorbed dose delivered to the 50% of the target volume
(𝐷
50%), conformation number (CN), and homogeneity index
(HI) according to the ICRU report 83 [16]. All parameters
were computed on the basis of the DVH.The CNwas defined








where CN is conformation number, TVRI is target volume
covered by the reference isodose, TV is target volume, and
𝑉RI is volume of the reference isodose. The CN ranged from
0 to 1, where 1 was the ideal value. A larger CN indicated a
smaller volume of the prescription dose delivered outside the





An HI of 0 indicated that the dose distribution was almost
homogenous. A larger HI indicated a greater dose exceeding
the prescribed dose and/or a larger volume of the target
receiving too small dose. The evaluation criteria of OARs









, and mean lung dose (MLD) values were
recorded and compared for normal lung, as well as the
maximum dose of the spinal cord, the mean and maximum
dose of the esophagus, the 𝐷
2%, 𝑉40, 𝑉60, and mean dose of
the heart.
2.8. Treatment Delivery Time and MUs. The Hybrid IMRT/
VMAT, IMRT, and VMAT plans for 15 patients were deliv-
ered to a solid water phantom (Multicube Phantom, IBA,
Germany) on the Trilogy linear accelerator. The treatment
delivery time and MUs were recorded and evaluated. The
treatment delivery time was defined as the time from first
beam on until last beam off.
2.9. Dosimetric Evaluation Stratified by Target Volume. In
order to investigate the target volume effect on the selection of
the optimal technique, we separated the 15 patients into two
groups according to the volumes of the PTVs, 8 patients with


































Figure 1: Representative axial, coronal, and sagittal computed tomography slices showing isodose distribution for (a) IMRT, (b) VMAT, and
(c) Hybrid IMRT/VMAT. Planning target volume (PTV) shown in red.
the PTV volumes smaller and 7 patients larger than the mean
volume of the PTVs (416.1 cm3). The dose distribution of
planning target volume (PTV) and organs at risk (OARs) for
Hybrid IMRT/VMAT was compared with IMRT and VMAT
for two groups separately.
2.10. Statistical Analysis. Paired two tailed 𝑡-test was used
to compare the three techniques. Statistical analysis was
performedusing the SPSS (version 13.0, Chicago, IL) forWin-
dows. Differences were reported to be statistically significant
at 𝑝 < 0.05.
3. Results
The mean volume of the PTV was 416.1 cm3 (173.4 cm3 to
887.0 cm3). For all 15 cases, all the plans were clinically
acceptable in terms of target coverage, with at least 98% PTV
receiving 95% of the prescribed dose. The typical isodose
distribution and DVH comparison were given in Figures 1
and 2 for a patient with stage IIIB nonsmall cell lung cancer.
The PTV was 414.0 cm3. The lesions were located in the right
hilus pulmonis and the upper lobe of the right lung. The
beams obtained by the beam angle optimization for IMRT are
39∘, 150∘, 210∘, 306∘, and 342∘. Two partial arcs of 0∘ ∼ 181∘ and
181∘ ∼ 0∘ were used for VMAT.
3.1. Target Coverage. The data for PTV coverage and OARs



































Figure 2: Representative dose volume histogram for IMRT, VMAT,
and Hybrid IMRT/VMAT.The curves of IMRT, VMAT, and Hybrid
IMRT/VMAT are indicated in solid lines, dashed lines, and dotted
lines, respectively.
were summarized in Tables 2 and 3. Hybrid IMRT/VMAT
significantly improved the target conformity compared with
IMRT and VMAT. The mean CN was 0.79, 0.86, and 0.88
for IMRT, VMAT, and hybrid plans, respectively. Hybrid
IMRT/VMAT also significantly improved the PTV dose
homogeneity compared with IMRT (9.8 versus 11.3; 𝑝 < 0.05)
andVMAT (9.8 versus 12.6; 𝑝 < 0.05). Compared with IMRT,
VMAT also improved the dose conformity.
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Table 2: The data for PTV coverage for IMRT, VMAT, and Hybrid IMRT/VMAT plans.
IMRT VMAT Hybrid IMRT versus VMAT IMRT versus Hybrid VMAT versus Hybrid
Mean ± SD Mean ± SD Mean ± SD 𝑝 value 𝑝 value 𝑝 value
PTV
𝐷
98% (Gy) 64.6 ± 0.5 64.6 ± 0.5 65.0 ± 0.3 >0.05 <0.05 <0.05
𝐷
2% (Gy) 72.6 ± 1.7 73.3 ± 1.7 71.5 ± 1.0 >0.05 <0.05 <0.05
CN 0.79 ± 0.05 0.86 ± 0.04 0.88 ± 0.03 <0.05 <0.05 <0.05
HI (%) 11.3 ± 0.7 12.6 ± 0.6 9.8 ± 0.3 <0.05 <0.05 <0.05
PTV is planning target volume, IMRT is intensity modulated radiation therapy, VMAT is volumetric modulated arc therapy, CN is conformation number, and
HI is homogeneity index.
Table 3: The data for OARs sparing for IMRT, VMAT, and Hybrid IMRT/VMAT plans.
IMRT VMAT Hybrid IMRT versus VMAT IMRT versus Hybrid VMAT versus Hybrid
Mean ± SD Mean ± SD Mean ± SD 𝑝 value 𝑝 value 𝑝 value
Normal lung
𝐷
















(%) 50.0 ± 8.2 60.3 ± 11.2 57.2 ± 10.7 <0.05 <0.05 <0.05
Mean (Gy) 14.2 ± 2.2 15.2 ± 2.6 14.6 ± 2.3 <0.05 <0.05 <0.05
Spinal cord
𝐷max (Gy) 41.5 ± 10.0 35.7 ± 10.5 35.9 ± 9.0 <0.05 <0.05 >0.05
Esophagus
𝐷max (Gy) 67.0 ± 5.7 66.2 ± 6.9 63.7 ± 7.9 >0.05 <0.05 <0.05
Mean (Gy) 22.9 ± 9.9 23.0 ± 9.6 22.4 ± 9.7 >0.05 <0.05 <0.05
Heart
𝐷
2% (Gy) 34.0 ± 25.7 31.3 ± 24.0 31.6 ± 23.8 >0.05 <0.05 >0.05








(%) 4.5 ± 5.6 2.8 ± 4.0 3.2 ± 4.4 <0.05 <0.05 >0.05
PTV is planning target volume, IMRT is intensity modulated radiation therapy, VMAT is volumetric modulated arc therapy, CN is conformation number, and
HI is homogeneity index.
∗
𝑉𝑁 is percentage volume of OARs receiving at least𝑁Gy of radiation dose.
3.2. Organs at Risk Sparing. The 𝑉
30
of normal lung for
hybrid plans was significantly lower than IMRT plans (17.7%
versus 18.7%; 𝑝 < 0.05) and VMAT plans (17.7% versus
18.4%; 𝑝 < 0.05). There was no significant difference in 𝑉
20





mean lung dose (MLD) of normal lung for hybrid plans were
12.6%, 8.6%, and 2.7% higher than those for IMRT plans,







normal lung for hybrid plans were 5.1%, 7.7%, 3.8%, and 3.9%
lower than those for VMAT plans, respectively (𝑝 < 0.05).
Themaximum doses of spinal cord and esophagus for hybrid
plans were 5.6Gy and 3.3Gy lower than those for IMRT plans
(𝑝 < 0.05).Themean doses of esophagus and heart for hybrid





of heart for hybrid plans were 27.3% and
28.9% lower than those for IMRT plans (𝑝 < 0.05).
3.3. Treatment Delivery Time and MUs. The mean delivery
time of hybrid planswas longer than that of IMRTplans (327 s
versus 280 s; 𝑝 < 0.05) and that of VMAT plans (327 s versus
114 s; 𝑝 < 0.05). The number of mean MUs of hybrid plans
(797 ± 81) was between the values of IMRT (997 ± 140) and
VMAT plans (509 ± 53).
3.4. Dosimetric Evaluation Stratified by Target Volume. For
the patients with the PTV volume smaller than 416.1 cm3,
the mean CN was 0.72, 0.86, and 0.89 for IMRT, VMAT,
and hybrid plans, respectively. Hybrid plans also significantly
improved the PTV dose homogeneity compared with IMRT
(9.9 versus 17.1; 𝑝 < 0.05) and VMAT (9.9 versus 14.9; 𝑝 <




of normal lung for hybrid plans
were 31.3% and 19.0%, with an absolute difference of 4.1%
and 1.1% lower than those for VMAT plans (𝑝 < 0.05),
respectively. The MLD for hybrid plans was 6.8Gy, 0.4Gy
lower than that for VMAT plans (𝑝 < 0.05). No difference
of 𝑉
20
of normal lung among the IMRT, VMAT, and hybrid
plans was found. The mean 𝑉
30
of normal lung for hybrid
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plans was 20.3% lower than that for IMRT plans (𝑝 < 0.05).
No significant differencewas found in themean𝑉
30
of normal
lung between hybrid and VMAT plans. The maximum dose
of spinal cord for hybrid plans was 27.6Gy, which was 4.3 Gy
lower than that for IMRT plans (𝑝 < 0.05). The mean dose
of esophagus for hybrid plans was 9.4Gy, which was 0.7Gy
lower than that for VMAT plans (𝑝 < 0.05). No differences in
the mean𝐷max of esophagus and𝐷2%, mean dose,𝑉60,𝑉40 of
heart among the IMRT, VMAT, and hybrid plans were found.
For the patients with the PTV volume larger than
416.1 cm3, the mean CN was 0.64, 0.80, and 0.83 for IMRT,
VMAT, and hybrid plans, respectively. Hybrid plans also
significantly improved the PTV dose homogeneity compared
with IMRT (10.0 versus 14.6; 𝑝 < 0.05). The mean 𝑉
5
of
normal lung for hybrid plans was 49.2%, with an absolute
difference of 4.4% lower than that for VMAT plans (𝑝 <
0.05), while no difference was found for 𝑉
10
between two
techniques. The MLD for hybrid plans was 10.4Gy, 0.6Gy





of normal lung among the IMRT, VMAT, and
hybrid plans were found. The maximum dose of spinal cord
for hybrid plans was 37.0Gy, whichwas 5.8Gy lower than that
for IMRTplans (𝑝 < 0.05). No differences of𝐷max,mean dose
of esophagus and𝐷
2%, mean dose,𝑉60,𝑉40 of heart among the
IMRT, VMAT, and hybrid plans were found.
4. Discussion
In this study, we investigated a Hybrid IMRT/VMAT tech-
nique for primary nonsmall cell lung cancer. Compared
with IMRT and VMAT, the improvements in conformity
and homogeneity with Hybrid IMRT/VMAT were especially
importantwhen the target was in close proximity to the spinal
cord limiting a satisfactory coverage of PTV. Compared
with IMRT, Hybrid IMRT/VMAT significantly reduced the
irradiated volume of the OARs and normal tissue receiv-
ing medium to high dose. Compared with VMAT, Hybrid
IMRT/VMAT reduced the volume of normal lung receiving
dose higher than 5Gy, 10Gy, 30Gy, and MLD significantly.





and MLD [14, 15, 17, 18] were correlated with radiation
pneumonitis, although the determination of the contributors
to radiation pneumonitis was challenging, since a variety of
treatment/patient-related factors appeared to influence this
risk.
There were several studies demonstrating that VMAT
could reduce delivery time and MUs compared with IMRT
[12–15]. Reduction of delivery time could decrease the pos-
sibility of the intrafraction patient motion that leads to
target underdosage and/or worse OARs sparing. However,
the treatment delivery time of hybrid plans was longer than
that of VMAT and IMRT plans in our study, because a hybrid
plan comprised of both a 5-field IMRT and a 2 partial arcs
VMAT. Liu et al. [19] reported that IMRT plans with fewer
beams (five or seven beams) could achieve dosimetric quality
comparable to those using nine equal-spaced beams, with
reduced MUs and field segments. Using nine equal-spaced




of normal lung. So, we used 5-field IMRT plans to
reduce the low dose distribution for normal lung. Chan et
al. [20] reported that, in their pilot study of using VMAT,
dosimetric distribution of one full arc was less favorable
compared to those with two half arcs. So, 2 partial arcs
VMATwas a good choice to compare with IMRT andHybrid
IMRT/VMAT.
Hybrid IMRT/VMAT improved the target dose confor-
mity and homogeneity compared with IMRT and VMAT,
while the difference of dose homogeneity of hybrid and
VMAT plans became insignificant for the patients with
the PTV volume larger than 416.1 cm3. The possible reason
was that IMRT and VMAT made compromises in different
aspects. IMRT achieved a reasonable dose distribution by
intensity modulation with limited angular beam sampling.
Due to the sparse angular sampling in IMRT, the conformity
of the resultant dose distribution was often limited. On the
other hand, while VMAT had sufficient angular sampling,
it did not provide the desired intensity modulation in some
beam directions. The final dose distribution depended on
the level of intensity modulation and angular sampling.
Hybrid IMRT/VMAT improved the target conformity and
homogeneity by increasing the freedom to find the optimal
combination of angular sampling and intensity modulation.
The reason for the insignificance of homogeneity difference
with increasing target volume between VMAT and hybrid
plans was perhaps due to the fact that the homogeneity satu-
rated by increasing the angular sampling in VMAT beyond
a certain level, with the side effect of spreading low dose,
which was also demonstrated as the reduced 𝑉
30
in VMAT
and hybrid plans compared with IMRT for smaller targets,
whereas no difference was found among three techniques for
larger targets.
Several recent publications have introduced hybrid tech-
niques which consisted of IMRT and arc with the purpose
of combining the efficiency of arc and OARs sparing of
IMRT. Martin et al. [17] reported that a novel IMRT &
Arc technique consisted of 4-field IMRT in conjunction
with a conformal arc. They demonstrated that for patients
with esophageal cancers the IMRT & Arc technique could
potentially improve the therapeutic ratio in reduction of car-
diorelated and pulmonary toxicity compared with plans for
either helical tomotherapy or single-arc RapidArc plans. The
forward planning for the conformal arc, as well as themanual
IMRT beam arrangement, was used in their study. Similarly,
Robar and Thomas [18] reported a HybridArc technique
combining optimized dynamic conformal arcs and IMRT. In
contrast to VMAT component in Hybrid IMRT/VMAT, the
arc component of IMRT&Arc andHybridArc did not involve
intensity modulation, for example, via dose rate or gantry
speed modulation, overlapping multiple arcs, or associated
linac functionality. Compared with Hybrid IMRT/VMAT
technique, the degrees of freedom of IMRT & Arc and
HybridArc were limited by (1) only a single pass by each
arc, (2) constant dose rate, and (3) constant gantry speed.
So no improvements in the brainstem and optic chiasm
sparing were found in HybridArc compared with IMRT
for the complex cranial cases. Chan et al. [20] reported
that the Hybrid-RapidArc technique utilizing two arcs with
additional static conformal fields could produce lower 𝑉
5
,
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𝑉
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, and MLD than double arcs RapidArc technique for lung
cancers. However, Hybrid-RapidArc failed to meet the plan
acceptance criteria due to the limited ability of intensity
modulation with the conformal radiotherapy component,
especially for the challenging cases (highly irregular PTV),
with involving mediastinal lymphadenopathy. Furthermore,
the ability to reduce the volume of normal lung receiving low
doses was limited, because the intensity of the static beams
could not be modulated to achieve good target conformity.
We developed a Hybrid IMRT/VMAT technique using
IMRT as the base plan and then optimized the VMAT plan
achieving trade-off between better dosimetric quality of
IMRT and delivery efficiency (fewer MUs) of VMAT. This
technique can be used on any treatment planning system
capable of producing both VMAT and IMRT plans. Addi-
tional research work on the Hybrid IMRT/VMAT strategy is
warranted in several areas. Most notable is to develop an
optimization algorithm which can optimize both VMAT and
IMRT simultaneously to determine the optimal propor-
tion of the prescribed dose for the IMRT and VMAT
components, the delivery sequence integrating the IMRT
and VMAT components. Furthermore, the types of can-
cer sites and geometries that will benefit most from
this Hybrid IMRT/VMAT technique should be further
investigated.
We investigated the influence of prescription dose ratio
between IMRT and VMAT in Hybrid IMRT/VMAT on the
dose distribution and delivery efficiency, by creating the plans
with the weighting of IMRT to VMAT of 1 : 1, 1 : 2, and 2 : 1.
The results demonstrated that better conformity, homogene-
ity, sparing of normal lung from higher dose irradiation, and
delivery efficiency were obtained with the increasing weight
of the VMAT, with the cost of increasing the volume of




) and MLD. In addition,
the ideal number of IMRT beams and VMAT arcs and the
start and stop angle of arcs in hybrid plans would likely vary
for different cases. For the representative case in this study,
the beam angles of the IMRT plan were optimized using
the beam angle optimization algorithm. Two right-anterior
oblique fields and a right-posterior oblique field with gantry
angles of 342∘, 306∘, and 210∘, a left-anterior oblique field with
gantry angle of 39∘, and a left-lateral field with gantry angle
of 150∘ were used. For the VMAT plan, two half arcs with the
gantry angle 181∘ to 0∘ and 0∘ to 181∘ were used.Wewill further
investigate a feasibility of automatic determination of these
parameters for the individual patients in the optimization, so
that the full potential of hybrid technique can be explored
and the hybrid plans can be planned and delivered together,
not separately. Hoover et al. [21] investigated an optimization
and delivery technique called united intensity-modulated
arc therapy (UIMAT), which optimized IMRT and VMAT
simultaneously and delivered IMRT and VMAT in the same
arc. They found that UIMAT has the potential to be superior
to IMRT or VMAT.
TheHybrid IMRT/VMAT technique can be implemented
to find the optimal compromise between gantry-angle and
intensity modulation degrees of freedom, dosimetric quality,
and delivery efficiency. It may be delivered without switching
between delivery techniques in the future. That is, hybrid
plans will be delivered as modulated arcs with IMRT inside,
that is, IMRT control points (with no gantrymotion) within a
VMAT control point sequence (with gantry changes) rather
than current two separate components, so that the delivery
time would be further reduced. In addition, the emergence of
autofield sequencing, which eliminates the unnecessary oper-
ator manual control of gantry rotation during dose delivery,
and the dramatically increased dose rate in modern digital
LINACs will make Hybrid IMRT/VMAT more efficient.
Our previous study demonstrated that some gantry
angles benefited plan quality themost frombeammodulation
for some specific targets and OARs configuration [22]. Li and
Xing [23] and Matuszak et al. [24] also demonstrated that an
additional modulation from “optimal” beam angle improved
plan quality compared with VMAT alone. While there were
some optimal beam orientations that would benefit from
IMRT, the selection of the best beamorientations formodula-
tion might become increasingly difficult for the complicated
cases. Li and Xing [23] proposed a dense angularly sampled
and sparse intensity modulated RT (DASSIM-RT) strategy,
in which a large number of beam angles were used to
increase the angular sampling while simplifying the intensity
modulation by eliminating the dispensable segments, to
improve dose distribution while maintaining high delivery
efficiency. In contrast with Hybrid IMRT/VMAT, DASSIM-
RT utilized an IMRT delivery mode, which could be time
intensive. In addition, the number of beams and intensity
level were arbitrarily selected in DASSIM-RT. Matuszak
et al. [24] reported a similar strategy called FusionArc and
proposed and validated gradient factor as the metric to find
the optimal IMRT beam directions. They used a single-arc
VMAT plan as the baseline plan and then converted selected
VMAT apertures with the highest gradient into IMRT beams.
Different from the arbitrarily selecting the number of beams
and intensity level in DASSIM-RT, and using one arc and
sequentially converting IMRTbeamone by one in FusionArc,
in our study, the Hybrid IMRT/VMAT integrated 5 IMRT
fields and 2 partial VMAT arcs, in which the optimal
IMRT beam directions were created by using beam angle
optimization, while the VMAT arcs were optimized with the
IMRT part as a base plan.
5. Conclusions
In combining VMAT and IMRT beams, Hybrid IMRT/
VMAT significantly improved both the target dose confor-
mity and the homogeneity compared with IMRT and VMAT







MLD of normal lung compared with VMAT and protected





, andmean lung dose (MLD) of normal lung compared
with IMRT. Hybrid IMRT/VMAT technique can be a viable
radiotherapy technique with better plan quality.
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